AstraZeneca PLC Capital Reinvestment Ratio
AstraZeneca PLC capital reinvestment ratio. AstraZeneca PLC (AZN) has a Capital Reinvestment Ratio of 0.26x as of June 2026, meaning it reinvests 0% of its operating cash flow ($2.89 Billion) in capital expenditures ($752.85 Million). Check AstraZeneca PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AstraZeneca PLC (1990–2025)
Capital reinvestment ratio of AstraZeneca PLC from 1990 to 2025. This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 36 annual periods. Also explore AstraZeneca PLC (AZN) equity growth momentum to track the company's year-over-year net asset growth rate.
AstraZeneca PLC Capital Reinvestment Ratio by Year (1990–2025)
AstraZeneca PLC capital reinvestment ratio by year from 1990 to 2025. For the full cash flow conversion analysis, see AstraZeneca PLC cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | $14.57 Billion | $5.91 Billion | ▲ +4.8% |
| 2024 | 0.39x | $11.86 Billion | $4.59 Billion | ▲ +5.9% |
| 2023 | 0.37x | $10.35 Billion | $3.78 Billion | ▲ +39.3% |
| 2022 | 0.26x | $9.81 Billion | $2.57 Billion | ▼ -29.0% |
| 2021 | 0.37x | $5.96 Billion | $2.20 Billion | ▼ -32.1% |
| 2020 | 0.54x | $4.80 Billion | $2.61 Billion | ▼ -34.5% |
| 2019 | 0.83x | $2.97 Billion | $2.46 Billion | ▲ +58.2% |
| 2018 | 0.52x | $2.62 Billion | $1.37 Billion | ▲ +15.7% |
| 2017 | 0.45x | $3.58 Billion | $1.62 Billion | ▼ -18.9% |
| 2016 | 0.56x | $4.14 Billion | $2.31 Billion | ▼ -33.4% |
| 2015 | 0.84x | $3.32 Billion | $2.79 Billion | ▲ +115.1% |
| 2014 | 0.39x | $7.06 Billion | $2.75 Billion | ▲ +40.2% |
| 2013 | 0.28x | $7.40 Billion | $2.06 Billion | ▼ -58.2% |
| 2012 | 0.66x | $6.95 Billion | $4.62 Billion | ▲ +300.9% |
| 2011 | 0.17x | $7.82 Billion | $1.30 Billion | ▼ -26.8% |
| 2010 | 0.23x | $10.68 Billion | $2.42 Billion | ▼ -10.0% |
| 2009 | 0.25x | $11.74 Billion | $2.96 Billion | ▼ -45.5% |
| 2008 | 0.46x | $8.74 Billion | $4.04 Billion | ▲ +106.7% |
| 2007 | 0.22x | $7.51 Billion | $1.68 Billion | ▲ +28.4% |
| 2006 | 0.17x | $7.69 Billion | $1.34 Billion | ▲ +19.9% |
| 2005 | 0.15x | $6.74 Billion | $979.00 Million | ▲ +113.1% |
| 2004 | 0.07x | $4.87 Billion | $332.00 Million | ▼ -81.8% |
| 2003 | 0.38x | $3.42 Billion | $1.28 Billion | ▲ +35.4% |
| 2002 | 0.28x | $4.83 Billion | $1.34 Billion | ▼ -66.8% |
| 2001 | 0.84x | $2.71 Billion | $2.26 Billion | ▲ +33.7% |
| 2000 | 0.63x | $2.34 Billion | $1.46 Billion | ▼ -79.4% |
| 1999 | 3.03x | $908.55 Million | $2.75 Billion | ▲ +215.4% |
| 1998 | 0.96x | $879.74 Million | $844.88 Million | ▼ -5.0% |
| 1997 | 1.01x | $747.21 Million | $755.47 Million | ▲ +24.7% |
| 1996 | 0.81x | $787.75 Million | $638.76 Million | ▲ +10.2% |
| 1995 | 0.74x | $585.64 Million | $431.11 Million | ▼ -6.5% |
| 1994 | 0.79x | $625.36 Million | $492.47 Million | ▲ +20.0% |
| 1993 | 0.66x | $705.58 Million | $462.99 Million | ▼ -66.7% |
| 1992 | 1.97x | $206.27 Million | $406.47 Million | ▲ +158.3% |
| 1991 | 0.76x | $505.22 Million | $385.46 Million | ▲ +13.9% |
| 1990 | 0.67x | $806.30 Million | $540.10 Million | — |